6 11, 2023 Shooting Cancer Highlights – Monthly focus on regulatory status of new targeted therapies in oncology – September and October 2023 adlitterio663392024-07-11T14:13:29+02:00 Mehr erfahren
28 06, 2023 Shooting Cancer- Highlights Monthly focus on regulatory status of new targeted therapies in oncology – April and May 2023 adlitterio663392023-06-28T10:28:18+02:00 Mehr erfahren
28 06, 2023 Shooting Cancer Highlights – Monthly focus on regulatory status of new targeted therapies in oncology – April and May 2023 adlitterio663392023-06-28T10:22:08+02:00 Mehr erfahren
1 04, 2023 Shooting Cancer Highlights – Monthly focus on regulatory status of new targeted therapies in oncology – February and March 2023 adlitterio663392023-06-28T10:54:57+02:00 Mehr erfahren
2 03, 2023 Shooting Cancer- Highlights Monthly focus on regulatory status of new targeted therapies in oncology – January 2023 adlitterio663392023-03-02T10:17:25+01:00 Mehr erfahren
11 01, 2023 Shooting Cancer- Highlights Monthly focus on regulatory status of new targeted therapies in oncology – November and December 2022 adlitterio663392023-01-11T12:15:44+01:00 Mehr erfahren
10 10, 2022 Shooting Cancer- Highlights Monthly focus on regulatory status of new targeted therapies in oncology – September2022 adlitterio663392022-10-10T13:45:31+02:00 Mehr erfahren
8 09, 2022 Shooting Cancer- Highlights Monthly focus on regulatory status of new targeted therapies in oncology – August 2022 adlitterio663392022-10-10T12:35:57+02:00 Mehr erfahren
4 08, 2022 Shooting Cancer- Highlights Monthly focus on regulatory status of new targeted therapies in oncology – July 2022 adlitterio663392022-08-04T09:43:40+02:00 Mehr erfahren
18 07, 2022 Monthly focus on regulatory status of new targeted therapies in oncology – June 2022 adlitterio663392022-07-18T11:33:44+02:00 Mehr erfahren
